Prescription Tranquilizer/Sedative Misuse Prevalence and Correlates Across Age Cohorts in the US
| dc.contributor.author | Schepis, Ty S. | |
| dc.contributor.author | Teter, Christian J. | |
| dc.contributor.author | Simoni-Wastila, Linda | |
| dc.contributor.author | McCabe, Sean Esteban | |
| dc.date.accessioned | 2020-03-16T20:07:18Z | |
| dc.date.available | 2020-03-16T20:07:18Z | |
| dc.date.issued | 2018-12 | |
| dc.description.abstract | Background: Prescription tranquilizer/sedative (e.g., alprazolam, zolpidem) misuse (i.e., use in ways not intended by the prescriber or without a prescription) is understudied, with little research identifying misuse correlates. Identification of key correlates could identify subgroups more likely to engage in misuse, allowing for targeted treatment. This work examines tranquilizer/sedative use and misuse prevalence rates and misuse correlates across U.S. age cohorts, using nationally representative data. Methods: Data were from the 2015-16 National Survey on Drug Use and Health (n = 114,043). Analyses used design-based logistic regression for past-year tranquilizer/sedative misuse correlates across participants or those engaged in past-year use; past-month misuse correlates were also examined in those with past-year misuse. Results: Young adults (18-25 years) had the highest prevalence of past-year and past-month tranquilizer/sedative misuse, with 42.8% of those with past-year use also engaged in misuse. Mental health correlates were associated with past-year misuse, while substance use, particularly opioid misuse, was associated with both past-year and past-month misuse. Substance use correlate strength was most likely to vary by age group, with older adults (65 years and older) having fewer significant correlates overall. Conclusions: This work highlighted young adults and those with other substance use as most likely to engage in tranquilizer/sedative misuse. In particular, those endorsing suicidality and reporting opioid misuse are a subgroup of concern, given their especially elevated rates of misuse and the increased risk for overdose imparted by tranquilizer/sedative medication. Workplace-based interventions for young adults and school-based universal prevention may be warranted to limit tranquilizer/sedative misuse in these groups. | |
| dc.description.department | Psychology | |
| dc.description.version | This is the accepted manuscript version of an article published in Addictive Behaviors. | |
| dc.format | Text | |
| dc.format.extent | 20 pages | |
| dc.format.medium | 1 file (.pdf) | |
| dc.identifier.citation | Schepis, T. S., Teter, C. J., Simoni-Wastila, L., McCabe, S. E. (2018). Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive Behaviors, 87, pp. 24-32. | |
| dc.identifier.doi | https://doi.org/10.1016/j.addbeh.2018.06.013 | |
| dc.identifier.issn | 1934-1687 | |
| dc.identifier.uri | https://hdl.handle.net/10877/9455 | |
| dc.language.iso | en | |
| dc.publisher | Routledge | |
| dc.source | Addictive Behaviors, 2018, Vol. 87, pp. 24-32. | |
| dc.subject | benzodiazepine | |
| dc.subject | misuse | |
| dc.subject | sedative | |
| dc.subject | tranquilizer | |
| dc.subject | age cohorts | |
| dc.subject | Psychology | |
| dc.title | Prescription Tranquilizer/Sedative Misuse Prevalence and Correlates Across Age Cohorts in the US | |
| dc.type | Article |